Taken together, our study reveals an essential role of circ_0057558/miR-206/ROCK1/AMPK axis in NAFLD and thus this axis could serve as a molecular target for future therapy development. The gene discussed is PRKAA1; the disease is metabolic dysfunction-associated steatotic liver disease.